2020
DOI: 10.3390/ijms21165603
|View full text |Cite
|
Sign up to set email alerts
|

A Plant-Derived Antigen–Antibody Complex Induces Anti-Cancer Immune Responses by Forming a Large Quaternary Structure

Abstract: The antigen–antibody complex (AAC) has novel functions for immunomodulation, encouraging the application of diverse quaternary protein structures for vaccination. In this study, GA733 antigen and anti-GA733 antibody proteins were both co-expressed to obtain the AAC protein structures in a F1 plant obtained by crossing the plants expressing each protein. In F1 plant, the antigen and antibody assembled to form a large quaternary circular ACC structure (~30 nm). The large quaternary protein structures induced imm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(13 citation statements)
references
References 51 publications
0
13
0
Order By: Relevance
“…The Fc fragment remarkably enhances the plasma half-life of their fused proteins or peptides through its FcRn interaction, eventually prolonging their therapeutic activities [43]. Additionally, the Fc fragment interacts with Fc receptors on immune cells to provoke antigen presentation, inducing immune responses [44,45]. Furthermore, regarding protein expression, the Fc-fused proteins in general exhibit better protein expression [29].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Fc fragment remarkably enhances the plasma half-life of their fused proteins or peptides through its FcRn interaction, eventually prolonging their therapeutic activities [43]. Additionally, the Fc fragment interacts with Fc receptors on immune cells to provoke antigen presentation, inducing immune responses [44,45]. Furthermore, regarding protein expression, the Fc-fused proteins in general exhibit better protein expression [29].…”
Section: Discussionmentioning
confidence: 99%
“…X57086) to construct the EpCAM-IgM Fc fusion protein, and this was cloned under the CaMV promoter in the plant expression vector pRCV2 to generate pRCV2 EpCAM-IgM Fc carrying the hygromycin phosphotransferase (hpt) gene for Chinese cabbage (B. rapa L. ssp. pekinensis) transformation [45]. The 30 amino acids (MATQRRANPSSLHLITVFSLLAAVVSAEVD) as an ER signal peptide from Nicotiana plumbaginifolia was fused to N-terminus of the cleavage site (Thr17-Ala23).…”
Section: Plant Expression Vector and Agrobacterium Strainmentioning
confidence: 99%
“…The Ag:IgG IC vaccination also induces functional humoral antibody responses to tumor Ags. In a recent study by Kim et al [ 97 ], a recombinant Ag antibody IC was generated. Through the production of recombinant GA733, an epithelial cell adhesion molecule (EpCAM), Fc fusion protein, and an anti-GA733 mAb, anti-GA733 IgG ICs were obtained.…”
Section: Targeting Dcs For Cancer Vaccination Via Fcγrs: Mechanistic Principlesmentioning
confidence: 99%
“…IgG ICs can be highly variable [ 105 ], and a disadvantage of full-length Ag:IgG ICs [ 97 ] is their undefined size and valency, a factor to keep in mind especially in the case of polyclonal ICs. From a clinical point of view, this intrinsic heterogeneity and potential folding alterations may hamper the establishment of clear molecular modes of action (MoA), a requirement for rational drug design.…”
Section: The Long Way To the Clinic: Lessons Learned From Translational Modelsmentioning
confidence: 99%
“…Moreover, unlike bacterial cells, plants have post-translational modification systems similar to those of mammalian cells, such as glycosylation. Since plant cells are eukaryotic and have an endomembrane system and secretory pathway ( Loh & Wayah, 2014 ), plants can produce and assemble correctly folded and complex mammalian proteins in their cells ( Menassa, Ahmad & Joensuu, 2012 ; Kim et al, 2020 (IJMS); Lee et al, 2020b (Plants)). Thus, plants are considered as an attractive alternative for the production of therapeutic recombinant proteins ( Lee & Ko, 2017 ; Nausch et al, 2012 ).…”
Section: Introductionmentioning
confidence: 99%